| 28-Jan-10 07:45AM | Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Intended for Autoimmune Disease Indications Business Wire |
| 27-Jan-10 01:23PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 26-Jan-10 12:51PM | Idera Pharma names MacCoss to board of directors AP -7.48% |
| 08:15AM | Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors Business Wire |
| 19-Jan-10 07:50PM | [$$] Small-Caps Get a Lift From Health Sector at The Wall Street Journal Online +13.77% |
| 07:46AM | InPlay: Idera Pharma announces achievement of clinical milestone under its collaboration with Merck for cancer treatment; entitled to receive ~$4.3 mln payment from Merck Briefing.com |
| 07:45AM | Idera Pharmaceuticals Announces Achievement of Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment Business Wire |
| 21-Dec-09 08:00AM | Idera Pharmaceuticals Announces Positive Interim Data from Phase 1 Clinical Trial of IMO-2125 in Chronic Hepatitis C Patients Business Wire +6.55% |
| 18-Dec-09 04:34PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04-Dec-09 08:00AM | Idera Pharmaceuticals Appoints Rahul Jasuja, Ph.D., Vice President of Corporate Development Business Wire |
| 25-Nov-09 02:02PM | Biotech Stocks: Incyte, Idera move on Novartis deals at MarketWatch |
| 12:14PM | Idera: Novartis deal ends, Merck pact extended AP |
| 08:28AM | Novartis terminates pact with Idera at MarketWatch |
| 08:00AM | Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants Business Wire |
| 07:34AM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online |
| 07:30AM | Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement Business Wire |
| 18-Nov-09 04:41PM | Biotech Stocks for a Possible Year-End Rally at Seeking Alpha |
| 10-Nov-09 09:04AM | IDERA PHARMACEUTICALS, INC. Financials EDGAR Online Financials |
| 08-Nov-09 09:19AM | New Star Analyst Rankings for Idera Pharmaceuticals, Inc. StarMine |
| 05-Nov-09 04:31PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 08:08AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:05AM | Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides Pipeline Update Business Wire |
| 03-Nov-09 08:00AM | Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009 Business Wire +5.01% |
| 30-Oct-09 01:00PM | A.H. Belo, Idera Pharmaceuticals: Biggest Price Gainers (AHC, IDRA) at The Wall Street Journal Online |
| 26-Oct-09 08:00AM | Idera Pharmaceuticals Announces Issuance of Patents Covering its Novel Toll-like Receptor-Targeted Compounds and Their Use Business Wire |
| 19-Oct-09 12:57PM | CORRECTED - CORRECTED-BRIEF-Idera acquires Sonar from BinaryWave at Reuters |
| 09:00AM | Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel in Arthritis Model Business Wire |
| 16-Oct-09 08:00AM | Idera Pharmaceuticals to Present at 8th Annual BIO Investor Forum Business Wire |
| 07-Oct-09 03:05PM | Idera launches Phase 1 Hepatitis C trial at bizjournals.com |
| 08:00AM | Idera Pharmaceuticals Initiates Phase 1 Clinical Trial of IMO-2125, a TLR9 Agonist, in Combination with Ribavirin for Chronic Hepatitis C Virus Infection Business Wire |
| 01-Oct-09 08:00AM | Idera Pharmaceuticals to Present at 11th Annual Massachusetts Biotechnology Investors Forum Business Wire |
| 25-Sep-09 09:00AM | Idera Pharmaceuticals Presents Final Data from Phase 2 Clinical Trial of IMO-2055 Monotherapy in Renal Cell Carcinoma Business Wire |
| 23-Sep-09 06:00AM | Idera Pharmaceuticals Presents Interim Data from Phase 1b Clinical Trial of IMO-2055 in Combination with Tarceva and Avastin in Non-Small Cell Lung Cancer Business Wire |
| 22-Sep-09 06:50AM | StockPreacher.com Issues Trading Outlook for CEL-SCI Corp GlobeNewswire |
| 17-Sep-09 09:56AM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 15-Sep-09 08:00AM | Idera Pharmaceuticals to Present at UBS Global Life Sciences Conference Business Wire |
| 03-Sep-09 08:00AM | Idera Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference Business Wire |
| 04-Aug-09 07:05AM | Idera Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides Pipeline Update Business Wire +7.31% |
| 07:00AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 31-Jul-09 08:00AM | Idera Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire -5.01% |
| 22-Jun-09 02:12PM | Universal Travel Group, China Medical Technologies and Stone Energy lead small-cap percentage losers SmallCapInvestor.com -11.87% |
| 16-Jun-09 10:00AM | Idera Pharmaceuticals Provides Update on Drug Candidate Pipeline Targeted to Toll-like Receptors Business Wire |
| 15-Jun-09 08:00AM | Idera Pharmaceuticals Announces Presentations of Preclinical Data on Modulation of Toll-like Receptors 3, 7, and 9 through Antisense Business Wire |
| 01-Jun-09 08:00AM | Idera Pharmaceuticals to Present at Noble Financial Capital Market's Fifth Annual Equity Conference Business Wire +10.68% |
| 15-May-09 08:00AM | Idera Pharmaceuticals to Present at BIO Business Forum and Participate in Panel at BIO 2009 Business Wire |
| 11-May-09 08:00AM | Idera Pharmaceuticals Announces Presentation of Preclinical Data on IMO-3100, a Lead TLR Antagonist Drug Candidate for Autoimmune Diseases, during American Association of Immunologists Annual Meeting Business Wire |
| 06-May-09 07:05AM | Idera Pharmaceuticals Reports First Quarter 2009 Financial Results Business Wire |
| 07:00AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 23-Apr-09 08:00AM | Idera Pharmaceuticals Announces Issuance of Patents Claiming Novel Toll-like Receptor-Targeted Immune Modulatory Oligonucleotides and Their Use Business Wire -5.46% |
| 15-Apr-09 08:00AM | Idera Pharmaceuticals to Present Preclinical Data on its Agonists of Toll-Like Receptors at AACR 2009 Annual Meeting Business Wire +10.83% |
| 11-Mar-09 10:26AM | Earnings roundup: National Semiconductor, Buckle AP |
| 08:06AM | Idera Pharmaceuticals reports 4Q profit AP |
| 07:15AM | Idera Pharmaceuticals Reports 2008 Fourth Quarter and Full Year Financial Results Business Wire |
| 07:02AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 10-Mar-09 09:18AM | Idera Pharmaceuticals to Present at Cowen and Company 29th Annual Health Care Conference Business Wire +6.21% |
| 04-Mar-09 08:00AM | Idera Pharmaceuticals Scientists Co-Author Paper on Preclinical Data of Investigational Cancer Vaccine Business Wire |
| 02-Feb-09 07:00AM | Idera Pharmaceuticals Announces Achievement of Clinical Milestone Under its Collaboration with Merck KGaA for Cancer Treatment Business Wire +5.71% |
| 30-Jan-09 08:00AM | Idera Pharmaceuticals to Present at Annual BIO CEO & Investor Conference 2009 Business Wire |
| 05-Jan-09 07:00AM | Idera Pharmaceuticals Announces Publication of Studies on Chemistry of Novel Antagonists for Toll-like Receptors 7 and 9 Business Wire +7.22% |
| 22-Dec-08 08:00AM | Massachusetts General Hospital and Idera Pharmaceuticals Receive Cooperative Research Grant from Massachusetts Life Sciences Center for Developing New Therapies for Lupus Business Wire -7.37% |
| 18-Dec-08 05:15PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E EDGAR Online |
| 17-Dec-08 02:05PM | Life Sciences Center begins granting at bizjournals.com |
| 08-Dec-08 09:49AM | Idera Pharmaceuticals to Present at 10th Annual Massachusetts Biotechnology Investors Forum Business Wire +6.80% |
| 21-Nov-08 09:35AM | Coverage initiated on Idera Pharma by Noble Financial Briefing.com |
| 20-Nov-08 07:30AM | Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors Business Wire -8.34% |
| 06-Nov-08 07:01AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:00AM | Idera Pharmaceuticals Reports Third Quarter 2008 Financial Results Business Wire |
| 27-Oct-08 08:00AM | Idera Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire -11.92% |
| 16-Oct-08 07:00AM | Idera Pharmaceuticals Presents Data from Autoimmune Disease Program at 4th Annual Meeting of the Oligonucleotide Therapeutics Society Business Wire +7.54% |
| 06-Oct-08 07:30AM | Idera Pharmaceuticals Announces Issuance of Patents for Novel Immune Modulatory Oligonucleotides Targeting Toll-Like Receptors and their Use Business Wire |
| 01-Oct-08 07:00AM | Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma Business Wire |
| 30-Sep-08 01:00PM | Idera Pharmaceuticals to Present at JMP Securities Healthcare Focus Conference Business Wire |
| 26-Sep-08 08:03AM | Zacks #1 Rank Additions for Friday Zacks.com |
| 24-Sep-08 08:37AM | Zacks #1 Rank Additions for Wednesday Zacks.com |
| 19-Sep-08 01:33PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 17-Sep-08 09:30AM | Idera Pharmaceuticals to Present at UBS Global Life Sciences Conference Business Wire -5.44% |
| 11-Sep-08 04:46PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities EDGAR Online |
| 02-Sep-08 08:00AM | Idera Pharmaceuticals Announces Milestone Payment Under Asthma and Allergy Collaboration Business Wire |
| 14-Aug-08 06:20AM | Idera Pharmaceuticals: On simmer SmallCapInvestor.com |
| 06-Aug-08 09:29AM | ILOG, Synchronoss Technologies and Idera Pharmaceuticals lead small-cap volume in pre-market SmallCapInvestor.com |
| 04-Aug-08 02:24PM | Earnings roundup: MDU Resources, Idera Pharma AP |
| 10:07AM | Idera Pharmaceuticals posts 2nd-quarter profit AP |
| 07:54AM | UPDATE - Idera Pharma posts Q2 profit at Reuters |
| 07:00AM | Idera Pharmaceuticals Reports Second Quarter 2008 Financial Results Business Wire |
| 01-Aug-08 05:01PM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 30-Jul-08 08:00AM | Idera Pharmaceuticals to Present at Upcoming Investor Conferences Business Wire |
| 30-Jun-08 02:16PM | Russell 2000 adds 53 health care companies AP -5.19% |
| 16-Jun-08 08:00AM | Idera Pharmaceuticals Forms Autoimmune Disease Scientific Advisory Board Business Wire |
| 13-Jun-08 08:50AM | Idera Pharmaceuticals to Present at BIO Business Forum 2008 Business Wire |
| 10-Jun-08 04:56PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online |
| 09-Jun-08 08:00AM | Idera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Models of Lung Inflammation and Psoriasis Business Wire |
| 23-May-08 03:45PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 12-May-08 08:00AM | Idera Pharmaceuticals Reports First Quarter 2008 Financial Results Business Wire |
| 07:01AM | IDERA PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 01-May-08 04:15PM | Hawaiian Holdings, Idera Pharmaceuticals and PrimeEnergy among 52-week highs SmallCapInvestor.com +5.43% |
| 08:00AM | Idera Pharmaceuticals Achieves Preclinical Milestone Under Collaboration with Merck & Co., Inc. Business Wire |
| 29-Apr-08 05:02PM | Idera Pharmaceuticals, Global Traffic Network and Versant among 52-week highs SmallCapInvestor.com |
| 28-Apr-08 04:03PM | IDERA PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities EDGAR Online |
| 17-Apr-08 03:30PM | Idera Pharmaceuticals Presents Data from Study of Toll-Like Receptor Antagonist in Preclinical Model of Multiple Sclerosis Business Wire |
| 09-Apr-08 08:00AM | Idera Pharmaceuticals to Present Preclinical Data of its Toll-Like Receptor-Targeted Compounds at AACR Meeting Business Wire |
